
Site burden is now measured through satisfaction surveys, in-the-moment check-ins, and adoption patterns, but each method catches a different moment, and the gaps between them decide whether teams can act before burden becomes risk.
Syneos Health, Inc., a biopharmaceutical solutions organization, announced the acquisition of Kinapse, a market advisory and operational solutions provider, from Hg, a specialist investor based in the U.K in order to further enhance end-to-end capabilities.
Read the full release






